Search Page

1

Cite

Share

Cannabinoids and Epilepsy.

Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O. Rosenberg EC, et al. Among authors: whalley bj. Neurotherapeutics. 2015 Oct;12(4):747-68. doi: 10.1007/s13311-015-0375-5. Neurotherapeutics. 2015. PMID: 26282273 Free PMC article. Review.

Cite

Share

2

Cite

Share

The proposed mechanisms of action of CBD in epilepsy.

Gray RA, Whalley BJ. Gray RA, et al. Among authors: whalley bj. Epileptic Disord. 2020 Jan 1;22(S1):10-15. doi: 10.1684/epd.2020.1135. Epileptic Disord. 2020. PMID: 32053110

Cite

Share

3

Cite

Share

Molecular Pharmacology of Phytocannabinoids.

Turner SE, Williams CM, Iversen L, Whalley BJ. Turner SE, et al. Among authors: whalley bj. Prog Chem Org Nat Prod. 2017;103:61-101. doi: 10.1007/978-3-319-45541-9_3. Prog Chem Org Nat Prod. 2017. PMID: 28120231 Review.

Cite

Share

4

Cite

Share

Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.

Russo E, Scicchitano F, Whalley BJ, Mazzitello C, Ciriaco M, Esposito S, Patanè M, Upton R, Pugliese M, Chimirri S, Mammì M, Palleria C, De Sarro G. Russo E, et al. Among authors: whalley bj. Phytother Res. 2014 May;28(5):643-55. doi: 10.1002/ptr.5050. Epub 2013 Jul 30. Phytother Res. 2014. PMID: 23897801 Review.

Cite

Share

5

Cite

Share

Molecular Targets of Cannabidiol in Neurological Disorders.

Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ. Ibeas Bih C, et al. Among authors: whalley bj. Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3. Neurotherapeutics. 2015. PMID: 26264914 Free PMC article. Review.

Cite

Share

6

Cite

Share

Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.

Patra PH, Barker-Haliski M, White HS, Whalley BJ, Glyn S, Sandhu H, Jones N, Bazelot M, Williams CM, McNeish AJ. Patra PH, et al. Among authors: whalley bj. Epilepsia. 2019 Feb;60(2):303-314. doi: 10.1111/epi.14629. Epub 2018 Dec 26. Epilepsia. 2019. PMID: 30588604 Free PMC article.

Cite

Share

7

Cite

Share

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Rosenberg EC, Patra PH, Whalley BJ. Rosenberg EC, et al. Among authors: whalley bj. Epilepsy Behav. 2017 May;70(Pt B):319-327. doi: 10.1016/j.yebeh.2016.11.006. Epub 2017 Feb 9. Epilepsy Behav. 2017. PMID: 28190698 Free PMC article. Review.

Cite

Share

8

Cite

Share

Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.

Jones NA, Hill AJ, Smith I, Bevan SA, Williams CM, Whalley BJ, Stephens GJ. Jones NA, et al. Among authors: whalley bj. J Pharmacol Exp Ther. 2010 Feb;332(2):569-77. doi: 10.1124/jpet.109.159145. Epub 2009 Nov 11. J Pharmacol Exp Ther. 2010. PMID: 19906779 Free PMC article.

Cite

Share

9

Cite

Share

Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.

Brierley DI, Harman JR, Giallourou N, Leishman E, Roashan AE, Mellows BAD, Bradshaw HB, Swann JR, Patel K, Whalley BJ, Williams CM. Brierley DI, et al. Among authors: whalley bj. J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):844-859. doi: 10.1002/jcsm.12426. Epub 2019 Apr 29. J Cachexia Sarcopenia Muscle. 2019. PMID: 31035309 Free PMC article. Clinical Trial.

Cite

Share

10

Cite

Share

Anabolic androgenic steroid abuse in the United Kingdom: An update.

Mullen C, Whalley BJ, Schifano F, Baker JS. Mullen C, et al. Among authors: whalley bj. Br J Pharmacol. 2020 May;177(10):2180-2198. doi: 10.1111/bph.14995. Epub 2020 Mar 3. Br J Pharmacol. 2020. PMID: 31989581 Free PMC article. Review.

Cite

Share